Showing results (851-860 of 3,241) with videos related to
Sort By:
Pageof 325
Journal of Clinical Pharmacy and Therapeutics|November 3, 2021
A Case of Cefepime-Induced Immune ThrombocytopeniaRebecca Bystrom, Minkey Wungwattana, Vatche TchekmedyianJournal of Clinical Pharmacy and Therapeutics|October 27, 2021
Real-world pharmacological treatment patterns of patients with threatened miscarriage in China from 2014 to 2020: A cross-sectional analysisYan-Yu Pang, Chun-Lai MaJournal of Clinical Pharmacy and Therapeutics|October 27, 2021
Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin-induced thrombocytopeniaKristen Cirbus, Pamela Simone, Jennifer Austin SzwakJournal of Clinical Pharmacy and Therapeutics|July 23, 2022
No two classes of biosimilars: Urgent advice to the US Congress and the FDASarfaraz K NiaziJournal of Clinical Pharmacy and Therapeutics|April 23, 2022
Clinical characteristics and treatment of terlipressin-induced ischemic skin necrosis: A synthesis of 35 literature reported casesYulu Zhou, Jiang Zeng, Liying Song, et al.Journal of Clinical Pharmacy and Therapeutics|February 1, 1993
The treatment of elderly hypertensive patientsM J Kendall, W Y Tse, A HeadJournal of Clinical Pharmacy and Therapeutics|August 1, 1994
Efficient phosphate binding using a combination of gluconolactate and carbonate calcium saltsJ Y Legendre, S Cote, D Pradeau, et al.Journal of Clinical Pharmacy and Therapeutics|August 1, 1994
Stability of rifampin in two suspensions at room temperatureM C Nahata, R S Morosco, T F HippleJournal of Clinical Pharmacy and Therapeutics|August 1, 1994
Correlation between nephrotoxicity and pharmacokinetic parameters of gentamicinY M el-SayedJournal of Clinical Pharmacy and Therapeutics|March 2, 2022
Evaluating the effectiveness of drug and therapeutics committees (DTCs) in controlling irrational drug use: A retrospective analysisJing Yang, Lei Zheng, Yu-Yao Guan, et al.Pageof 325